ImmuneOnco Biopharmaceuticals (Shanghai) Management
Management criteria checks 3/4
ImmuneOnco Biopharmaceuticals (Shanghai)'s CEO is Tian Wenzhi, appointed in Jun 2015, has a tenure of 9.17 years. total yearly compensation is CN¥43.86M, comprised of 6.6% salary and 93.4% bonuses, including company stock and options. directly owns 18.76% of the company’s shares, worth HK$874.48M. The average tenure of the management team and the board of directors is 2.4 years and 6.8 years respectively.
Key information
Tian Wenzhi
Chief executive officer
CN¥43.9m
Total compensation
| CEO salary percentage | 6.6% |
| CEO tenure | 9.2yrs |
| CEO ownership | 18.8% |
| Management average tenure | 2.4yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | CN¥44m | CN¥3m | -CN¥379m |
| Sep 30 2023 | n/a | n/a | -CN¥371m |
| Jun 30 2023 | n/a | n/a | -CN¥362m |
| Mar 31 2023 | n/a | n/a | -CN¥382m |
| Dec 31 2022 | CN¥56m | CN¥2m | -CN¥403m |
| Dec 31 2021 | CN¥8m | CN¥2m | -CN¥733m |
Compensation vs Market: Tian's total compensation ($USD6.14M) is above average for companies of similar size in the Hong Kong market ($USD425.01K).
Compensation vs Earnings: Tian's compensation has been consistent with company performance over the past year.
CEO
Tian Wenzhi (60 yo)
9.2yrs
Tenure
CN¥43,858,000
Compensation
Dr. Tian Wenzhi is Founder, CEO, Chief Scientific Officer & Chairman of the Board of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Dr. Wenzhi joined the ImmuneOnco Biopharmaceuticals (Shanghai) Inc. on Jun...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.2yrs | CN¥43.86m | 18.76% CN¥ 874.5m | |
| VP of R&D and Executive Director | no data | CN¥992.00k | no data | |
| Senior VP & Chief Medical Officer | 2.4yrs | no data | no data | |
| Senior Vice President | 2.4yrs | no data | no data | |
| Senior Vice President | 2.3yrs | no data | no data | |
| Deputy GM & Senior VP | 7.5yrs | no data | no data | |
| Secretary | 2.3yrs | no data | no data | |
| Joint Company Secretary | 2.2yrs | no data | no data |
2.4yrs
Average Tenure
42.5yo
Average Age
Experienced Management: 1541's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.2yrs | CN¥43.86m | 18.76% CN¥ 874.5m | |
| VP of R&D and Executive Director | 8.7yrs | CN¥992.00k | no data | |
| Secretary | less than a year | no data | no data | |
| Independent Non-Executive Director | 8yrs | no data | no data | |
| Chairman of the Supervisory Committee | 8.4yrs | no data | no data | |
| Non-Executive Director | 3.8yrs | no data | no data | |
| Non-Executive Director | 6.4yrs | no data | no data | |
| Non-Executive Director | 8.7yrs | no data | no data | |
| Independent Non-Executive Director | 2.2yrs | CN¥353.00k | no data | |
| Independent Non-Executive Director | 2.2yrs | CN¥270.00k | no data | |
| Supervisor | 7.1yrs | no data | no data | |
| Employee Representative Supervisor | 2.6yrs | no data | no data |
6.8yrs
Average Tenure
46.5yo
Average Age
Experienced Board: 1541's board of directors are considered experienced (6.8 years average tenure).